GlassScriptPhysician profile
Paula K Lapinski
NPI 1437262482
$263.94
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2021: $39.99 · 2022: $51.21 · 2023: $30.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.50 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.50 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $33.67 | 2022 | |
| Genentech USA, INC. | $33.21 | 2019 | |
| Abbvie INC. | $29.80 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $29.09 | 2019 | |
| Galderma Laboratories, L.P. | $23.81 | 2019 | |
| Sandoz INC. | $21.86 | 2019 | |
| Tactile Systems Technology INC | $19.70 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.50 | 2023 | Cyltezo |
| Pfizer INC. | $15.27 | 2023 | |
| Allergan, INC. | $14.50 | 2021 | |
| Merck Sharp & Dohme LLC | $14.30 | 2019 | |
| Sun Pharmaceutical Industries INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Lapinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.